Study of LY2140023 in Schizophrenia Comparing LY2140023, Olanzapine, and Placebo
Clinical trial NCT00149292 · COMPLETED
Trial details
- NCT number
- NCT00149292
- Sponsor
- Denovo Biopharma LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-08-23
- Primary completion
- 2006-07-17
- Enrollment
- 195
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.